Back to Peptide Pedia
Healing & Recovery
Emerging Research

Follistatin 344

FST-344

Myostatin-binding research protein.

Also known as: FS-344

Research dose range100 mcg daily (research models)
Route studiedSubcutaneous / intramuscular
Study durationShort courses (e.g., ~10–30 days)
Storage2–8 °C reconstituted

Overview

Follistatin 344 is a research protein studied in muscle-development and myostatin-regulation models for its role in tissue growth.

Key research findings

A glycoprotein studied for its ability to bind and inhibit myostatin (GDF-8), the primary negative regulator of muscle growth. By neutralizing myostatin, research models report increased muscle mass — the basis for substantial interest in muscle-wasting and growth research.

Mechanism of action

Binds and inhibits myostatin and related TGF-beta family ligands, studied for promoting muscle growth in research models.

Molecular information

Weight~38–49 kDa (glycoprotein)
Length344-amino-acid isoform
TypeMyostatin/activin-binding glycoprotein

Follistatin-344 is one of several isoforms; circulating vs. tissue-bound distribution differs by variant.

Pharmacokinetics

Peak: ~few hoursHalf-life: ~Hours to ~1 dayCleared: ~3 days
Peak · 0.1dHalf-life · 0.5d

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Muscle-development research
  • Myostatin-regulation studies
  • Tissue-growth investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Standard referenceAmount: 100 mcgFrequency: Once dailyRoute: Subcutaneous
Short-course referenceAmount: 100 mcgFrequency: Daily ~10–30 daysRoute: Intramuscular

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Week 1–2

    Myostatin-inhibition signaling reported in muscle-research models.

  2. Week 2–4

    Muscle-mass changes reported; short courses are typical in study designs.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

IGF-1 LR3

Both promote muscle growth via different pathways; monitored in research.

Use caution

PEG-MGF

Complementary growth pathways; overlapping anabolic signaling.

Use caution

Thymosin Beta-4

Distinct repair vs. myostatin pathways.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl very gently, and refrigerate — glycoproteins are fragile and degrade with agitation.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved — do not shake.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • As a systemic growth regulator, broad off-target effects are a theoretical consideration in the literature.
  • Human data are limited; most evidence is preclinical or gene-therapy-based.

References & further reading

Follistatin and myostatin regulation of muscle mass (review)

Preclinicalmyostatin inhibitionmuscle

Review of follistatin's myostatin-binding activity and its effect on muscle-mass regulation.

View study

Topics

myostatinmusclegrowth

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Emerging Research

Active but early-stage research; evidence still developing.

Quick reference
Dose range100 mcg daily (research models)
RouteSubcutaneous / intramuscular
DurationShort courses (e.g., ~10–30 days)
Storage2–8 °C reconstituted
Half-life~Hours to ~1 day
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue